We demonstrate that CD8 T cells induced by tumor implantation are superior to CD8 T cells induced by a vaccine at preventing secondary tumor growth, and that this concomitant tumor immunity is dependent on CD40L and can occur independent of CD4 T cells. Here, CD8A is linked to neoplasm.